Open AccessAbstract 73: Inhibition of ACK1 delays and overcomes acquired resistance of EGFR mutant NSCLC cells to the third generation EGFR inhibitor, osimertinib
Author(s) -
Jian Gu,
Xia He,
Nupam P. Mahajan,
Taofeek K. Owonikoko,
Suresh S. Ramalingam,
Shi-Yong Sun
Publication year - 2019
Publication title -
cancer research
Language(s) - English
Resource type - Conference proceedings
eISSN - 1538-7445
pISSN - 0008-5472
DOI - 10.1158/1538-7445.am2019-73
Subject(s) - t790m , osimertinib , cancer research , apoptosis , cell culture , egfr inhibitors , mutant , medicine , gene knockdown , cancer , biology , epidermal growth factor receptor , gefitinib , gene , erlotinib , biochemistry , genetics